Magnetic resonance elastography shows that locations of brain stiffening differ in common dementia types.
Quantitative MR elastography (MRE) of changes in brain viscoelastic structure shows unique regional brain stiffness patterns among common dementia subtypes, according to a study published in the American Journal ofRoentgenology.
Researchers from the Mayo Clinic in Rochester, MN, sought to investigate age-corrected brain MRE findings in subjects with Alzheimer disease, dementia with Lewy bodies, frontotemporal dementia, and normal pressure hydrocephalus, and determine the potential use as a differentiating biomarker in dementia subtypes.
The study included 84 participants who all underwent MRE:
• 20 with normal pressure hydrocephalus
• 8 with Alzheimer disease
• 5 with dementia with Lewy bodies
• 5 with frontotemporal dementia
• 46 cognitively normal control subjects
Using shear waves of 60-Hz vibration frequency transmitted into the brain using a pillow-like passive driver, the researchers determined brain stiffness in eight regions:
• Cerebrum
• Frontal
• Occipital
• Parietal
• Temporal
• Deep gray matter–white matter
• Sensorimotor cortex
• Cerebellum
The results showed regional stiffness patterns unique to each dementing disorder. Patients with Alzheimer disease and frontotemporal dementia showed decreased cerebral stiffness with regional softening of the frontal and temporal lobes. They also additionally showed parietal lobe and sensorimotor region softening. Patients with normal pressure hydrocephalus showed stiffening of the parietal, occipital, and sensorimotor regions and those with dementia with Lewy bodies did not show significant stiffness changes in any of the regions.
The researchers concluded that quantitative MRE of changes in brain viscoelastic structure showed unique regional brain stiffness patterns among common dementia subtypes.
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.